About this Research Topic
This topic issue will cover the frontiers in IBD therapy, from diagnostics guiding therapy, prioritising biologics, fecal transfer, real world versus study world to ambulatory versus hospital care as well as novel surgical and pyschological issues in IBD. Additional manuscripts in this area of IBD therapy are very welcome and should be submitted by October 2022. Coeditors are myself (Chief section editor), Klaus Herrlinger and Thomas Klag, both associate editors of Therapy in Gastroenterology.
Keywords: IBD Therapy, prioritising biologics, fecal transfer, diagnostic guiding, therapy, IBD therapy in times of Covid 19
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
